1674-0440
2010 Issue 5
Antidepressant-like effect of a novel compound YL-0919,a dual 5-HT1A agonist and serotonin reuptake inhibitor
LI Kai;CHEN Hong-xia;YUAN Li;ZHANG Li-ming;WANG Yi-wen;ZHANG You-zhi;YANG Ri-fang;LI Yun-feng
LI Kai;CHEN Hong-xia;YUAN Li;ZHANG Li-ming;WANG Yi-wen;ZHANG You-zhi;YANG Ri-fang;LI Yun-feng
..............page:366-371
Chemical constituents and pharmacologic actions of genus Peganum: research advances
ZHAO Ting;WANG Chang-hong;WANG Zheng-tao
ZHAO Ting;WANG Chang-hong;WANG Zheng-tao
..............page:333-339,345
Study on the chemical consitituents of Galium aparine L.
LI Jian;CHEN Li;LI Bin;LIU Shi-jun;DONG Jun-xing
LI Jian;CHEN Li;LI Bin;LIU Shi-jun;DONG Jun-xing
..............page:387-389
..............page:321-328
Synthesis and evaluation of conjugates of gemcitabine and polyglutamic acid with amino acids as linkers
WANG Yong-guang;HE Xin-hua;ZHONG Bo-hua
WANG Yong-guang;HE Xin-hua;ZHONG Bo-hua
..............page:382-386
Protective effect of alanyl-glutamine dipeptide on acute gastric ulcer in rats
WANG Jian-xing;XUE Yan-ping;GUAN Lei;JIN Ying;WANG Yong-an
WANG Jian-xing;XUE Yan-ping;GUAN Lei;JIN Ying;WANG Yong-an
..............page:372-376
Design, synthesis and evaluation of novel hydroxyethylamine derivatives with nitrogen heterocyclic moiety at N-terminal as BACE1 inhibitors
ZHAO Kan;HE Jun-lin;ZHOU Jin-wu;CHENG Jun-ping;CHENG Xiao-rui;ZHOU Wen-xia;LIU Ke-liang
ZHAO Kan;HE Jun-lin;ZHOU Jin-wu;CHENG Jun-ping;CHENG Xiao-rui;ZHOU Wen-xia;LIU Ke-liang
..............page:377-381
Dipeptidyl peptidase Ⅳ inhibitors:a new class of oral agents for treatment of type 2 diabetes mellitus
CAI Le;LIU Ping
CAI Le;LIU Ping
..............page:361-365
Macrophage colony-stimulating factor receptor and its inhibitors: research advances
YANG Sheng-qian;WANG Li-li
YANG Sheng-qian;WANG Li-li
..............page:340-345
..............page:371,376,381,390-400
Pregnane X receptor and multidrug resistance
WANG Tian-xiao
WANG Tian-xiao
..............page:329-332
Metabonomics analytical technologies and metabolite identification
WANG Chao;TU Wen-zhi;WANG Mu;RANG Wei-qing
WANG Chao;TU Wen-zhi;WANG Mu;RANG Wei-qing
..............page:355-360
A20 binding inhibitor of nuclear factor-κB activation: research advances
WANG Xiao;ZHOU Pei-lan;GONG Ze-hui
WANG Xiao;ZHOU Pei-lan;GONG Ze-hui
..............page:346-349,360
Development of pharmacogenomics and individual therapy in cardiovascular and cerebrovascular drugs
LUO Jun-rong;CAO Jian;XIAO Le-yi;JING Hong-juan
LUO Jun-rong;CAO Jian;XIAO Le-yi;JING Hong-juan
..............page:350-354